US Patent Issued to Merck Sharp & Dohme on April 1 for "Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors" (New Jersey, Massachusetts, New York Inventors)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,134, issued on April 1, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors" was invented by Dane Clausen (Rahway, N.J.), Ping Chen (Edison, N.J.), Xavier Fradera (Brookline, Mass.), Liangqin Guo (Monroe Township, N.J.), Yongxin Han (Needham, Mass.), Shuwen He (Fanwood, N.J.), Xianhai Huang (Warren, N.J.), Joseph Kozlowski (Princeton, N.J.), Guoqing Li (Belle Mead, N.J.), Theodore A. Martinot (Southborough, Mass.), Alexander Pasternak (Jamaica Plain, Mass.), Andreas Verras (New York), Li Xiao (Cranbury, N.J.), Feng Ye (Scotch Plains, N.J.), Wensheng Yu (Edison, N.J.) and Rui Zhang (Plainsbo...